Keyword: generics

News

EU to Fine Lundbeck, Others for Blocking Generic Drugs

03.06.2013 - A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...

Logistics & Supply Chain

Interview with Angelos Orfanos, DHL: Life Science Demands Advanced Infrastructure

03.06.2013 - Logistics - Globalization, outsourcing and a trend towards generics and biopharmaceuticals are some of the key factors shaping todays supply chains for the life sciences and...

News

India's Sun Pharma in Talks to Buy Sweden's Meda for $5-$6 Billion

01.06.2013 - India's Sun Pharmaceutical Industries is in talks to buy Sweden's Meda for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with...

News

Pfizer to Spin Off Zoetis Stake to Shareholders

23.05.2013 - Pfizer said on Wednesday it will spin off its majority stake in animal health business Zoetis to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7%...

News

Actavis to Buy Warner Chilcott in $5 Billion Stock Deal

20.05.2013 - Generic drugmaker Actavis, which has been the subject of takeover speculation, plans to buy specialty pharmaceutical company Warner Chilcott for $5 billion in stock. The companies...

News

Sanofi Fined in Plavix Generics Dispute

14.05.2013 - The French Competition Authority fined drugmaker Sanofi €40.6 million ($52.7 million) on Tuesday for "disparaging" generic competition to its Plavix blood thinner. The decision on...

News

Drugmakers Face More Scrutiny of Discordant U.S. Prices

11.05.2013 - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer and...

News

Teva Pharmaceutical Banks on Thrice-weekly Copaxone

02.05.2013 - Teva Pharmaceutical Industries is banking on approval in early 2014 for a new thrice-weekly version of its multiple sclerosis treatment Copaxone to bolster sales ahead of a likely...